Login to Your Account



As Merck Funds Stimuvax

Oncothyreon $40M Stock Sale Will Fund Earlier-Stage Pipeline

By Trista Morrison


Monday, May 2, 2011
Taking advantage of a recent stock bump, Oncothyreon Inc. raised $40 million in a public offering.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription